Abrey-Recalde MJ, Mialhe F, Le TK, Radoua A, Lagorgette L, Belkaid R, Mamode Cassim A, Gonzalez D, Jacquin E, Gobbo J, Bibeau F, Lepage C, Xu L, He X, Derangère V, Lirussi F, Jego G, Ye XY, Hermetet F, Garrido C

Cell Death Dis. 2026 05 19;:

Phosphatidylcholine and CHPT1 as Central Drivers of Chemoresistance in Colorectal Cancer: Lipidomic and Functional Insights.

Mialhe A, Pais de Barros JP, Hermetet F, Limagne E, Ghiringhelli F, Aires V, Delmas D

Cells. 2026 02 28;15(5):

Plasmalogen remodeling modulates macrophage response to cytotoxic oxysterols and atherosclerotic plaque vulnerability.

Jalil A, Pilot T, Bourgeois T, Laubriet A, Li X, Diedisheim M, Deckert V, Magnani C, Le Guern N, Pais de Barros JP, Nguyen M, Pallot G, Vouilloz A, Proukhnitzky L, Hermetet F, Aires V, Lesniewska E, Lagrost L, Auwerx J, Le Goff W, Venteclef N, Steinmetz E, Thomas C, Masson D

Cell Rep Med. 2025 05 6;:102131

Lipid metabolism in cancer: Exploring phospholipids as potential biomarkers.

Delmas D, Mialhe A, Cotte AK, Connat JL, Bouyer F, Hermetet F, Aires V

Biomed Pharmacother. 2025 04 29;187:118095

Current Advances in the Combination of Fatty Acids and Resveratrol to Fight Ocular Diseases.

Delmas D, Perus M, Aires V, Hermetet F

Mol Nutr Food Res. 2025 04 7;:e70037

First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphoma.

Gibouin VC, Durand M, Boudesco C, Hermetet F, Nozickova K, Chassagne-Clement C, Abdelwahed M, Klener P, Garrido C, Jego G

Leukemia. 2024 06 21;:

VEGF-R2/CAV-1 Interaction Induced by Resveratrol/Eicosapentaenoic Acid/Docosahexaenoic Acid-Enriched Formulation through Functional Detergent-Resistant Membranes Is Associated with Decreased VEGF-A Release in ARPE-19 Cells.

Perus M, Courtaut F, Pais de Barros JP, Aires V, Hermetet F, Delmas D

Mol Nutr Food Res. 2024 05 19;:e2300893

Development of an Immuno-SPECT/Fluorescent Bimodal Tracer Targeting Human or Murine PD-L1 on Preclinical Models.

Privat M, Massot A, Hermetet F, Al Sabea H, Racoeur C, Mabrouk N, Cordonnier M, Moreau M, Collin B, Bettaieb A, Denat F, Bodio E, Bellaye PS, Goze C, Paul C

J Med Chem. 2024 01 25;:

Emergence of Lipid Droplets in the Mechanisms of Carcinogenesis and Therapeutic Responses.

Delmas D, Cotte AK, Connat JL, Hermetet F, Bouyer F, Aires V

Cancers (Basel). 2023 08 14;15(16):

GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC.

Mabrouk N, Racoeur C, Shan J, Massot A, Ghione S, Privat M, Dondaine L, Ballot E, Truntzer C, Boidot R, Hermetet F, Derangère V, Bruchard M, Végran F, Chouchane L, Ghiringhelli F, Bettaieb A, Paul C

Cancers (Basel). 2023 06 9;15(12):

Red Wine Extract Prevents Oxidative Stress and Inflammation in ARPE-19 Retinal Cells.

Cornebise C, Perus M, Hermetet F, Valls-Fonayet J, Richard T, Aires V, Delmas D

Cells. 2023 05 17;12(10):

Tannic Acid, A Hydrolysable Tannin, Prevents Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition to Counteract Colorectal Tumor Growth.

Barboura M, Cornebise C, Hermetet F, Guerrache A, Selmi M, Salek A, Chekir-Ghedira L, Aires V, Delmas D

Cells. 2022 11 17;11(22):

Resvega, a Nutraceutical Preparation, Affects NFκB Pathway and Prolongs the Anti-VEGF Effect of Bevacizumab in Undifferentiated ARPE-19 Retina Cells.

Sghaier R, Perus M, Cornebise C, Courtaut F, Scagliarini A, Olmiere C, Aires V, Hermetet F, Delmas D

Int J Mol Sci. 2022 10 3;23(19):

NF-κB signaling controls H3K9me3 levels at intronic LINE-1 and hematopoietic stem cell genes in cis.

Pelinski Y, Hidaoui D, Stolz A, Hermetet F, Chelbi R, Diop MK, Chioukh AM, Porteu F, Elvira-Matelot E

J Exp Med. 2022 08 1;219(8):

Genetic Background of Polycythemia Vera.

Regimbeau M, Mary R, Hermetet F, Girodon F

Genes (Basel). 2022 Apr 2;13(4):

PD-1/PD-L1 Checkpoints and Resveratrol: A Controversial New Way for a Therapeutic Strategy.

Delmas D, Hermetet F, Aires V

Cancers (Basel). 2021 Sep 7;13(18):

Lactobacillus stress protein GroEL prevents colonic inflammation.

Dias AMM, Douhard R, Hermetet F, Regimbeau M, Lopez TE, Gonzalez D, Masson S, Marcion G, Chaumonnot K, Uyanik B, Causse SZ, Rieu A, Hadi T, Basset C, Chluba J, Grober J, Guzzo J, Neiers F, Ortega-Deballon P, Demidov ON, Lirussi F, Garrido C

J Gastroenterol. 2021 Mar 29;:

Nanofitins targeting heat shock protein 110: an innovative immunotherapeutic modality in cancer.

Marcion G, Hermetet F, Neiers F, Uyanik B, Dondaine L, Dias AMM, Da Costa L, Moreau M, Bellaye PS, Collin B, Gobbo J, Briand L, Seigneuric R, Kitten O, Cinier M, Garrido C

Int J Cancer. 2021 Jan 27;:

High-fat diet intensifies MLL-AF9-induced acute myeloid leukemia through activation of the FLT3 signaling in mouse primitive hematopoietic cells.

Hermetet F, Mshaik R, Simonet J, Callier P, Delva L, Quéré R

. 2020 Sep 30;10(1):16187

Fiche personne Projets Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques

Dr HERMETET François

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Recherche

Projets

Radiosensibilisation par des formulations riches en acides gras polyinsaturés et polyphénols : positionnement d'adjuvants thérapeutiques à la radiothérapie

Publications

Combining PD-L1 blockade with a second-generation HSP110 inhibitor enhances antitumor immunity in colorectal cancer.